JP2023531252A5 - - Google Patents
Info
- Publication number
- JP2023531252A5 JP2023531252A5 JP2022580096A JP2022580096A JP2023531252A5 JP 2023531252 A5 JP2023531252 A5 JP 2023531252A5 JP 2022580096 A JP2022580096 A JP 2022580096A JP 2022580096 A JP2022580096 A JP 2022580096A JP 2023531252 A5 JP2023531252 A5 JP 2023531252A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- cancer
- chain containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025283168A JP2026053657A (ja) | 2020-06-26 | 2025-12-25 | 抗b7-h3抗体を含む抗体-薬物コンジュゲート |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063044764P | 2020-06-26 | 2020-06-26 | |
| US63/044,764 | 2020-06-26 | ||
| PCT/IB2021/000445 WO2021260438A1 (en) | 2020-06-26 | 2021-06-25 | Antibody-drug conjugates comprising anti-b7-h3 antibodies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025283168A Division JP2026053657A (ja) | 2020-06-26 | 2025-12-25 | 抗b7-h3抗体を含む抗体-薬物コンジュゲート |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023531252A JP2023531252A (ja) | 2023-07-21 |
| JP2023531252A5 true JP2023531252A5 (cg-RX-API-DMAC7.html) | 2024-07-02 |
| JP7798811B2 JP7798811B2 (ja) | 2026-01-14 |
Family
ID=79282029
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022580096A Active JP7798811B2 (ja) | 2020-06-26 | 2021-06-25 | 抗b7-h3抗体を含む抗体-薬物コンジュゲート |
| JP2025283168A Pending JP2026053657A (ja) | 2020-06-26 | 2025-12-25 | 抗b7-h3抗体を含む抗体-薬物コンジュゲート |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025283168A Pending JP2026053657A (ja) | 2020-06-26 | 2025-12-25 | 抗b7-h3抗体を含む抗体-薬物コンジュゲート |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12168060B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4171655A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7798811B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230028793A (cg-RX-API-DMAC7.html) |
| CN (2) | CN115942978A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021297036A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022026401A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3182602A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL299362A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022016180A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021260438A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112166115A (zh) | 2018-05-29 | 2021-01-01 | 尹图赛利有限公司 | 新型苯二氮杂*衍生物及其用途 |
| EP3873912B1 (en) | 2018-10-31 | 2026-03-25 | Intocell, Inc. | Fused heterocyclic benzodiazepine derivatives and uses thereof |
| CN114728075B (zh) * | 2019-12-02 | 2025-10-03 | 尹图赛利有限公司 | 与分子缀合相关的组合物和方法 |
| CN115942978A (zh) | 2020-06-26 | 2023-04-07 | 尹图赛利有限公司 | 包含抗b7-h3抗体的抗体-药物缀合物 |
| MX2024008036A (es) * | 2021-12-28 | 2024-07-15 | Beigene Switzerland Gmbh | Conjugados de anticuerpo y farmaco. |
| AU2022446336A1 (en) * | 2022-03-18 | 2024-09-19 | Beijing Mabworks Biotech Co., Ltd | B7-h3-binding antibody and use thereof |
| CN120417939A (zh) * | 2022-10-28 | 2025-08-01 | 伊莱利利公司 | 用于生物缀合的自水解马来酰亚胺 |
| TW202438527A (zh) * | 2023-03-17 | 2024-10-01 | 瑞士商百濟神州瑞士有限責任公司 | 抗b7h3抗體以及其使用方法 |
| WO2024225838A1 (ko) * | 2023-04-28 | 2024-10-31 | 주식회사 에이비켐바이오 | 균일한 dar을 갖는 말레이미드 함유 링커를 포함하는 항체-약물 중합체의 제조방법 |
| CN120957756A (zh) * | 2023-05-12 | 2025-11-14 | 四川科伦博泰生物医药股份有限公司 | 稠环化合物及其制备方法和用途 |
| CN116949044B (zh) * | 2023-09-20 | 2023-12-12 | 北京炫景瑞医药科技有限公司 | 一种双链寡链核苷酸、包含该双链寡核苷酸的缀合物以及它们的用途 |
| CN117717536A (zh) * | 2023-11-03 | 2024-03-19 | 吉林农业大学 | 一种玉米醇溶蛋白胶囊的制备工艺 |
| CN117777296B (zh) * | 2024-02-28 | 2024-05-28 | 北京肿瘤医院(北京大学肿瘤医院) | B7h3亲和体及其诊疗核素标记物的制备方法与应用 |
| WO2025237246A1 (en) * | 2024-05-11 | 2025-11-20 | Westlake Laboratory Of Life Sciences And Biomedicine | Novel covalent protein and use thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6613304B2 (ja) | 2014-09-17 | 2019-12-04 | ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 抗cd276抗体(b7h3) |
| CN109069633A (zh) * | 2016-04-15 | 2018-12-21 | 宏观基因有限公司 | 新颖的b7-h3-结合分子、其抗体药物缀合物及其使用方法 |
| RS61828B1 (sr) * | 2016-06-08 | 2021-06-30 | Abbvie Inc | Anti-b7-h3 antitela i antitelske konjugacije lekova |
| CA3056474A1 (en) * | 2017-03-31 | 2018-10-04 | Jiangsu Hengrui Medicine Co., Ltd. | B7-h3 antibody, antigen-binding fragment thereof and medical use thereof |
| KR102710962B1 (ko) * | 2017-07-04 | 2024-09-27 | 주식회사 인투셀 | 절단성 링커를 포함하는 화합물 및 이들의 용도 |
| CN112166115A (zh) * | 2018-05-29 | 2021-01-01 | 尹图赛利有限公司 | 新型苯二氮杂*衍生物及其用途 |
| EP3873912B1 (en) * | 2018-10-31 | 2026-03-25 | Intocell, Inc. | Fused heterocyclic benzodiazepine derivatives and uses thereof |
| KR102732027B1 (ko) * | 2019-07-09 | 2024-11-20 | 주식회사 와이바이오로직스 | B7-h3(cd276)에 특이적으로 결합하는 항체 및 그의 용도 |
| CN115942978A (zh) | 2020-06-26 | 2023-04-07 | 尹图赛利有限公司 | 包含抗b7-h3抗体的抗体-药物缀合物 |
-
2021
- 2021-06-25 CN CN202180050283.9A patent/CN115942978A/zh active Pending
- 2021-06-25 KR KR1020237002842A patent/KR20230028793A/ko active Pending
- 2021-06-25 JP JP2022580096A patent/JP7798811B2/ja active Active
- 2021-06-25 IL IL299362A patent/IL299362A/en unknown
- 2021-06-25 CN CN202310829257.7A patent/CN116999571A/zh active Pending
- 2021-06-25 US US17/358,306 patent/US12168060B2/en active Active
- 2021-06-25 AU AU2021297036A patent/AU2021297036A1/en active Pending
- 2021-06-25 MX MX2022016180A patent/MX2022016180A/es unknown
- 2021-06-25 BR BR112022026401A patent/BR112022026401A2/pt unknown
- 2021-06-25 CA CA3182602A patent/CA3182602A1/en active Pending
- 2021-06-25 EP EP21829799.2A patent/EP4171655A4/en active Pending
- 2021-06-25 WO PCT/IB2021/000445 patent/WO2021260438A1/en not_active Ceased
-
2024
- 2024-09-06 US US18/827,143 patent/US20250121087A1/en active Pending
-
2025
- 2025-12-25 JP JP2025283168A patent/JP2026053657A/ja active Pending